APT Medical Inc. / Fundamentals
Income statement
- Net revenue
€275.89M - Cost of goods sold
€75.15M - Gross profit
€200.73M - SG&A expenses
€24.73M - R&D expenses
€38.00M - EBITDA
€101.51M - D&A
€0.00 - EBIT
€102.58M - Interest expenses
€252.72K - EBT
€101.03M - Tax expenses
€11.87M - Net income
€91.50M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€53.60M - Changes in working capital
€0.00 - Operating cash flow
€76.07M - Capex
€41.36M - Other investing cash flow
€33.72M - Net investing cash flow
€985.50K - Total cash dividends paid
-€36.82M - Issuance of common stock
-€8.45M - Debt repayment
€341.19K - Other financing cash flow
-€2.40M - Net financing cash flow
-€38.88M - Foreign exchange effects
-€1.44M - Net change in cash
€41.68M - Cash at end of period
€128.98M - Free cash flow
€117.43M
Balance sheet
- Cash and cash equivalents
€131.18M - Cash and short-term investments
€145.98M - Total receivables
€11.57M - Inventory
€53.40M - Other current assets
€4.76M - Total current assets
€215.71M - Property, plant & equipment
€91.30M - Goodwill
€5.83M - Intangible assets
€47.91M - Long-term investments
€21.27M - Other non-current assets
€4.48M - Total non-current assets
€174.46M - Total assets
€390.17M - Accounts payable
€9.78M - Short-term debt
€0.00 - Other current liabilities
€26.58M - Total current liabilities
€42.15M - Long-term debt
€1.16M - Deferred tax liabilities
€312.72K - Other non-current liabilities
€122.91K - Total non-current liabilities
€5.46M - Total liabilities
€47.61M - Common stock
€17.07M - Retained earnings
€229.25M - Other equity
€9.45M - Total equity
€342.56M - Total liabilities and shareholders' equity
€390.17M
Company information
- Market capitalization
€4.98B - Employees
2.2K - Enterprise Value
€38.45B
Company ratios
- Gross margin
-
72.8% Better than peer group: 64.0% - EBITDA margin
-
36.8% Better than peer group: 29.2% - EBIT margin
-
37.2% Better than peer group: 24.7% - EBT margin
-
36.6% Better than peer group: 26.2% - Net margin
-
33.2% Better than peer group: 22.5% - ROE
-
26.7% Better than peer group: 18.4% - ROA
-
23.5% Better than peer group: 14.7% - Asset turnover
-
70.7% Much better than peer group: 50.4% - FCF margin
-
12.6% Better than peer group: -1.3% - FCF yield
0.7% - Efficiency ratio
63.2% - Net sales per employee
-
€128.02K - Net income per employee
-
€42.46K